skip to Global Navigation Bar skip to main content


homeHome > About Us > Press Release > News

News

News Content
Daewoong Pharmaceuticals disseminates the excellence of ‘Nabota’ in IMCAS
Date 2016-08-02 Hit 14109
list
News List
Prev Daewoong Pharmaceuticals signs 29 billion won export contract with Jordan and Iraq
Next Daewoong Pharmaceutical’s ‘NABOTA’ becomes the first Korea-made Botulinum Toxin to obtain US FDA approval